Journal profile · Medicine-General Medicine
Advances in Drug and Alcohol Research
ISSN 2674-0001 · Frontiers Media S.A. · Switzerland
Advances in Drug and Alcohol Research: fully open access; APC about USD 2,500; median 116 days to acceptance (14 articles, last 24 months); 8 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Advances in Drug and Alcohol Research is published by Frontiers Media S.A.. By OpenAlex counts of its recent articles, its largest topics are Substance Abuse Treatment and Outcomes, Alcohol Consumption and Health Effects and Prenatal Substance Exposure Effects, together about 39.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
ADAR’s mission is to utilize INRC and IDARS’ multidisciplinary expertise, technological advancements and translational tools to enhance collaboration of scientists around the world not only to improve drug and alcohol abuse therapeutics, but to seek diverse cell, gene and proteomic, neuro-immuno-microbiome targets to treat drug addiction. An outstanding Editorial Board of international researchers supports the Editor-in-Chief Emmanuel Onaivi, a Professor at William Paterson University in New Jersey USA. This multidisciplinary Open Access journal welcomes and will publish original manuscripts, commentaries, reviews on all drugs of abuse using diverse in-vitro and in-vivo molecular, cellular and systems biological approaches in pre-clinical models and clinical studies. Special issues and section editors will be dedicated to highlight key areas of psychostimulant, opiates, alcohol, cannabis and cannabinoids, hallucinogens and psychiatric co-morbidities along with the growing food and digital addictions. The journal of Advances in Drug and Alcohol Research will use Frontiers’ transformative Open Access platform and aims to be the global Open Access leader in all fields of the science of drug and alcohol abuse and addiction. All publications receive objective and rigorous peer-review processes. Furthermore, ADAR aims to bring together drug and alcohol abuse scientists and clinicians from across the globe to share and discuss the current state of knowledge, challenges and the future of drug addiction that continues to be a global problem. Frontiers’ transparent peer-review approach allows authors to interact with reviewers and editors to improve the articles for publication. ADAR would like to recognize Dr Michael Kuhar, Emeritus Professor and Editor, has contributed to many publications with IDARS over the years.
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editorial board by country: 1 in mainland China (about 2%); most named United States 35, Japan 2, France 2, Mexico 2, Argentina 2 (50 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Substance Abuse Treatment and OutcomesMedicine16.8%
- Alcohol Consumption and Health EffectsMedicine12.7%
- Prenatal Substance Exposure EffectsMedicine10.4%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience6.4%
- Opioid Use Disorder TreatmentMedicine6.4%
- Cannabis and Cannabinoid ResearchMedicine5.2%
- Neuropeptides and Animal PhysiologyNeuroscience5.2%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
Other: Google Scholar, EBSCO, Dimensions, CNKI, CLOCKSS, Crossref, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 5.5LetPub ·
- CiteScore (publisher)
- 5.5Publisher website ·
- SJR 2026-06
- 0.89LetPub ·
- SNIP 2026-06
- 1.31LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 20OpenAlex ·
- 2-year mean citedness
- 2.52OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 73 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 11 | 11 | 175 |
| 2025 | 8 | 8 | 207 |
| 2024 | 10 | 10 | 118 |
| 2023 | 27 | 27 | 52 |
| 2022 | 13 | 13 | 14 |
| 2021 | 4 | 4 | 2 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
116 daysMedian, submission to acceptance · P25–P75 80 days – 145 days
- Acceptance to online
- median 21 days (14 articles)
- Submission to online
- median 132 days
- Sample
- 14 articles with submission and acceptance dates (14 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,500 | Yes | CC BY | |
| OpenAlex | USD 2,500 | — | — | |
| LetPub | USD 2,500 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Keywords
- ≥ 5
- Reference style
- Vancouver
Policy excerpts from the journal's websiteLicense & copyright, Open access
- License & copyright 2.1. CC-BY Licence
All figures, tables, and images will be published under a Creative Commons CC-BY licence, and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, follow any citation instructions requested by third-party rights holders, …
Source ↗Publisher website ·- Open access Open Access Statement
ADAR provides online free gold open access to the journal and all of its research publications.Open Access funder and institutional mandates: ADAR is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution licence (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Co…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2674-0001
- Society / sponsor
- International Drug and Alcohol Research Society and the International Narcotics Research Conference
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Advances in Drug and Alcohol Research
How long does peer review take at Advances in Drug and Alcohol Research?
Based on the dates recorded on 14 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 116 days (interquartile range 80–145 days); authors report an average review time of about 15 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Advances in Drug and Alcohol Research?
According to the journal's author guidelines: Keywords: ≥ 5; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Advances in Drug and Alcohol Research based?
Of the 50 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (35), Japan (2) and France (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Advances in Drug and Alcohol Research?
According to LetPub and DOAJ records, Advances in Drug and Alcohol Research is indexed in Scopus and DOAJ. The journal's website also lists PMC; that list has not been checked against each database.
Is Advances in Drug and Alcohol Research open access, and what is the APC?
Advances in Drug and Alcohol Research is a fully open-access journal. APC about USD 2,500.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .